It is with deep regret and sadness we advise that our former President and long-time colleague Dr Rod Moore passed away on Thursday 21 September 2023.
Dr Rod Moore, provided many years of dedicated service to MDA National, demonstrating unwavering commitment to the organisation and our Members, not only as President, but also serving on a number of committees. He worked tirelessly to advocate our vision, bringing exceptional medical knowledge to risk management. In addition, he was always ready and available to meet with or communicate with our Members, holding their best interests at heart.
Dr Moore was first elected to the MDA National (MDAN) Mutual Board in 1998 and served as Vice President from 2004 to 2007. He was the Acting Chairman of the Mutual Board from October 2014 until 19 March 2015, when the Mutual Board elected him as President, a position he held until his retirement from the Board in November 2020. Dr Moore was appointed to the Board of MDA National Insurance (a wholly owned subsidiary of MDAN) as an alternate director in February 2004 and was later appointed in his own right from 2007 to November 2020.
Dr Moore was a member of the MDAN Group's Remuneration & Nominations Committee, Capital Committee, and MDA National Insurance’s Clinical Underwriting Committee and chaired the Cases (Western/Central) Committee, as well as an active participant in many other working groups and committees throughout his involvement with MDA National.
As the founding Principal of two multidisciplinary sports medicine clinics in Perth, Western Australia, he had a long involvement with Australian Football League (AFL), having been the team doctor for the West Coast Eagles (1987 – 2012) and was a graduate of the Australian Institute of Company Directors and previously a Board member of HBF Health Ltd.
The deep understanding of and involvement in the medical indemnity industry over 22 years had resulted in Dr Moore making a significant impact on the quality of health care delivered by MDA National Members to patients across Australia. This was demonstrated by a combination of personal leadership at the Board, management, and all levels within the organisation as well as participation with various national and international industry bodies.
Dr Moore’s personal interest in corporate governance contributed to Board stability and effectiveness in providing outstanding strategic and operational guidance and direction to the organisation which has been critical to the successful negotiation of the challenges experienced by the medical profession and the organisation through the COVID-19 pandemic.
Dr Moore gave of his time freely and was always ready to meet with or communicate with any MDA National Members who needed his advice or mentorship. He often made himself available to staff to discuss cases and other issues. He was always respectful of others’ opinions, even when they differ from his own, and had a great sense of propriety in his actions.
We extend our heartfelt sympathy to family and friends and thank Dr Moore for his outstanding and selfless contribution to MDA National.